Cargando…
ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
Cancer is a major public health problem around the world and the key leading cause of death in the world. It is well-known that glucolipid metabolism, immunoreaction, and growth/death pattern of cancer cells are markedly different from normal cells. Recently, acyl-CoA synthetase long-chain family 4...
Autores principales: | Hou, Jun, Jiang, Changqing, Wen, Xudong, Li, Chengming, Xiong, Shiqiang, Yue, Tian, Long, Pan, Shi, Jianyou, Zhang, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326356/ https://www.ncbi.nlm.nih.gov/pubmed/35910359 http://dx.doi.org/10.3389/fphar.2022.949863 |
Ejemplares similares
-
Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR
por: Tao, Wen-hui, et al.
Publicado: (2022) -
ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
por: Yang, Yufei, et al.
Publicado: (2022) -
Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis
por: Fan, Zhenyu, et al.
Publicado: (2021) -
Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023) -
Itraconazole Inhibits the Growth of Cutaneous Squamous Cell Carcinoma by Targeting HMGCS1/ACSL4 Axis
por: Xu, Congcong, et al.
Publicado: (2022)